Central and mixed apneas in children with obstructive sleep apnea: effect of adenotonsillectomy

Joselina Antunes1, João Carvalho2, Carolina Marinho2

  • 1Otorhinolaryngology, Head and Neck Surgery Department, Professor Doutor Fernando Fonseca Hospital, IC19, 2720-276, Amadora, Portugal. Joselina.antunes@hff.min-saude.pt.

Insights

Adenotonsillectomy significantly improves mixed apnea index (MAI) and central apnea index (CAI) in children with moderate-to-severe obstructive sleep apnea syndrome (OSAS). This surgery normalizes non-obstructive apneas in most affected children.

Area of Science:

  • Pediatric Sleep Medicine
  • Otolaryngology
  • Respiratory Physiology

Background:

  • Obstructive sleep apnea syndrome (OSAS) in children often presents with mixed and central apneas.
  • Non-obstructive apneas are frequently observed in pediatric OSAS, impacting treatment strategies.

Purpose of the Study:

  • To investigate the impact of adenotonsillectomy on mixed apnea index (MAI) and central apnea index (CAI).
  • To evaluate the effectiveness of adenotonsillectomy in children with moderate-to-severe OSAS and non-obstructive apneas.

Main Methods:

  • Retrospective analysis of polysomnographic data from 80 children with moderate-to-severe OSAS.
  • Children without comorbidities undergoing adenotonsillectomy were included.

Main Results:

  • Adenotonsillectomy led to significant reductions in MAI (1.2 to 0.5) and CAI (1.0 to 0.5).
  • Post-surgery, 91.7% of children showed normalized MAI and 75.6% normalized CAI.
  • The study included 80 children (55 boys, 25 girls) with a median age of 3.6 years.

Conclusions:

  • Adenotonsillectomy effectively reduces both obstructive and non-obstructive apneas in children with moderate-to-severe OSAS.
  • The procedure demonstrates significant improvements in MAI and CAI, suggesting its benefit for central and mixed apneas.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
157
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
263
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
2.2K
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
423
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
114
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
717